• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2022-07-26 14:24 原文鏈接: EPOR基因突變與藥物因子介紹

    該基因編碼紅細胞生成素受體,紅細胞生成素受體是細胞因子受體家族的一員。在促紅細胞生成素結合后,該受體激活JAK2酪氨酸激酶,激活不同的細胞內途徑,包括:ras/map激酶、磷脂酰肌醇3激酶和stat轉錄因子。受刺激的促紅細胞生成素受體似乎在紅細胞存活中起作用。紅細胞生成素受體缺陷可導致紅白血病和家族性紅細胞增多。這種基因的失調可能影響某些腫瘤的生長。交替剪接導致多個轉錄變體。
    This gene encodes the erythropoietin receptor which is a member of the cytokine receptor family. Upon erythropoietin binding, this receptor activates Jak2 tyrosine kinase which activates different intracellular pathways including: Ras/MAP kinase, phosphatidylinositol 3-kinase and STAT transcription factors. The stimulated erythropoietin receptor appears to have a role in erythroid cell survival. Defects in the erythropoietin receptor may produce erythroleukemia and familial erythrocytosis. Dysregulation of this gene may affect the growth of certain tumors. Alternate splicing results in multiple transcript variants.

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频